S22.089S Insurance Policy Changes

ICD-10 S22.089S is officially defined as "Unspecified fracture of T11-T12 vertebra, sequela." code S22.089S is referenced in 5 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code S22.089S is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 5, 2026Medium impact
Infrared Therapy (CPB 0604, reviewed 2026-09-09)
Aetna considers infrared coagulation medically necessary for anal dysplasia and for members with grade I, II, or III internal hemorrhoids that are painful or persistently bleeding. Low-level infrared light therapy is considered experimental, investigational, or unproven for a long list of indications, including osteoarthritis, migraines, stroke, and diabetes mellitus, and the infrared glove is unproven for Raynaud's syndrome and all other indications. CPT 46930 is covered when selection criteria are met, while CPT 97026 and HCPCS codes A4639 and E0221 are not covered for the listed indications.
Aetna · Identified Aug 19, 2026Medium impact
Mechanical Stretching Devices for Contracture and Joint Stiffness (CPB 0405, reviewed 2026-06-30)
Aetna covers dynamic splinting devices for the knee, elbow, wrist, finger or toe when there are documented signs and symptoms of significant motion stiffness or loss and the splint is used as an adjunct to occupational or physical therapy at least 3 weeks after injury or surgery, or when the member has a documented history of motion loss in a joint and is in the acute post-operative period after a second or subsequent surgery. The policy also covers the dynamic adjustable ankle extension/flexion device (e.g., JAS Ankle) for contractures, the EZ Turnbuckle orthosis after open reduction internal fixation for radial head fracture, and continued mechanical stretching when documented improvement in range of motion is shown. Dynamic splinting for carpal tunnel syndrome, cerebral palsy, foot drop associated with neuromuscular diseases, multiple sclerosis, stroke and plantar fasciitis, JAS splints, PASS devices such as the ERMI flexionators and extensionators, SaeboMas, Medi-Dyne Prostretch, and mechanical stretching for skin graft contracture are considered experimental, investigational or unproven.
Aetna · Identified Aug 19, 2026Medium impact
Zoledronic Acid (CPB 0524, reviewed 2026-02-12)
Aetna's clinical policy bulletin covers zoledronic acid for commercial medical plans. Zoledronic acid 5 mg (Reclast or generic) is considered medically necessary for postmenopausal osteoporosis, osteoporosis in men, glucocorticoid-induced osteoporosis, Paget's disease of bone, and treatment-related bone loss in men with prostate cancer receiving androgen deprivation therapy, when the listed criteria are met. Zoledronic acid 4 mg (formerly branded Zometa) is considered medically necessary for bone metastases from a solid tumor, certain breast cancer indications, hypercalcemia of malignancy, Langerhans cell histiocytosis with bone disease, multiple myeloma, and systemic mastocytosis with osteopenia or osteoporosis. Aetna considers all other indications experimental, investigational, or unproven.
Aetna · Identified Aug 16, 2026Medium impact
Seat Lifts and Patient Lifts (CPB 0459, reviewed 2026-07-16)
Aetna covers seat lift mechanisms as durable medical equipment only when the member cannot stand up from a regular armchair at home, has severe arthritis of the hip or knee or severe neuromuscular disease, the device is prescribed to effect improvement or arrest or slow deterioration, and the member can ambulate once standing. Stand-assist lifts, patient lifts, bariatric lifts, and multi-positional transfer systems are covered only when their own separate criteria are met, and spring-release seat lifts with a catapult-type motion are considered experimental, investigational, or unproven. the policy was last reviewed 07/16/2026.
Aetna · Identified Aug 12, 2026Medium impact
Orthopedic Casts, Braces and Splints (CPB 0009, reviewed 2026-01-20)
Aetna considers orthoses, casts and splints medically necessary when they treat disease or injury for the listed indications, including lumbar and thoracic-lumbar-sacral braces that facilitate healing after a spine injury or spinal surgery, post-operative back braces applied within 6 weeks after spinal surgery, cervical braces for neck injury and torticollis, Unna boots for non-fracture care, air casts for fractures or other injuries, and prefabricated volar wrist braces for carpal tunnel syndrome. Prophylactic lumbar supports are considered experimental, investigational, or unproven, and elastic support garments and protective body socks do not meet Aetna's definition of covered durable medical equipment. Custom-fitted back braces are medically necessary where there is a failure, contraindication or intolerance to an unmodified, prefabricated back brace, and medical record documentation must support all coverage criteria because supplier-prepared statements and practitioner attestations alone are not sufficient.

Watch S22.089S

Get one email when a payer policy names S22.089S, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code S22.089S?

There are 5 tracked policy changes affecting code S22.089S, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code S22.089S?

Payers that have issued tracked updates for code S22.089S include: Aetna.

How do I get notified when code S22.089S policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code S22.089S. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code S22.089S?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Infrared Therapy (CPB 0604, reviewed 2026-09-09)

Mechanical Stretching Devices for Contracture and Joint Stiffness (CPB 0405, reviewed 2026-06-30)

Zoledronic Acid (CPB 0524, reviewed 2026-02-12)

Seat Lifts and Patient Lifts (CPB 0459, reviewed 2026-07-16)

Orthopedic Casts, Braces and Splints (CPB 0009, reviewed 2026-01-20)

What insurance policy changes affect code S22.089S?

Which payers have updated policy for code S22.089S?

How do I get notified when code S22.089S policy changes?

Why do payers change policies for code S22.089S?